Your browser doesn't support javascript.
loading
Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol.
Colhoun, Helen M; Leiter, Lawrence A; Müller-Wieland, Dirk; Cariou, Bertrand; Ray, Kausik K; Tinahones, Francisco J; Domenger, Catherine; Letierce, Alexia; Israel, Marc; Samuel, Rita; Del Prato, Stefano.
Affiliation
  • Colhoun HM; The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. helen.colhoun@igmm.ed.ac.uk.
  • Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Müller-Wieland D; Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
  • Cariou B; l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France.
  • Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College, London, UK.
  • Tinahones FJ; Department of Clinical Endocrinology and Nutrition (IBIMA), Hospital Virgen de la Victoria, University of Málaga, CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Málaga, Spain.
  • Domenger C; Sanofi, Gentilly, France.
  • Letierce A; Biostatistics and Programming Department, Sanofi, Chilly-Mazarin, France.
  • Israel M; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA.
  • Samuel R; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA.
  • Del Prato S; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Cardiovasc Diabetol ; 19(1): 14, 2020 02 08.
Article in En | MEDLINE | ID: mdl-32035487

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protease Inhibitors / Triglycerides / Diabetes Mellitus, Type 2 / Dyslipidemias / Antibodies, Monoclonal, Humanized / PCSK9 Inhibitors / Cholesterol, HDL / Anticholesteremic Agents Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2020 Document type: Article Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protease Inhibitors / Triglycerides / Diabetes Mellitus, Type 2 / Dyslipidemias / Antibodies, Monoclonal, Humanized / PCSK9 Inhibitors / Cholesterol, HDL / Anticholesteremic Agents Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2020 Document type: Article Country of publication: Reino Unido